Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-22-Speech-3-195"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-09-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20100922.20.3-195"2
lpv:hasSubsequent	lp_eu:2010-09-22-Speech-3-9742
lpv:speaker	lp:Edite Estrela2
lpv:spokenAs	member; S&D (2009-07-14--2014-06-30)3 unknown; Partido Socialista (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the People's Republic of China (2009-09-16--2014-06-30)3 substitute; EMPL (2009-07-16--2012-01-18)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 member; ENVI (2009-07-16--2012-01-18)3 member; Delegation for relations with the Mercosur countries (2009-09-16--2014-06-30)3 vice-chair; FEMM (2009-07-16--2012-01-18)3
lpv:translated text	"I voted in favour of the report on the proposal for a regulation of the European Parliament and of the Council amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. I did so because the agreement reached with the Council will make it possible to establish an effective and transparent European pharmacovigilance system, particularly through the creation of a European drug safety web portal and means for patients to report adverse reactions to the competent national authorities."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph